Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 8;8(1):647-658.
doi: 10.3233/ADR-230172. eCollection 2024.

Cognitive Impairment in the Post-Acute Phases of COVID-19 and Mechanisms: An Introduction and Narrative Review

Weiye Wang  1 , Ruxin Cui  2 , Luming Leng  1 , Gang Wang  3 , Guoping Peng  1
Affiliations
Review

Cognitive Impairment in the Post-Acute Phases of COVID-19 and Mechanisms: An Introduction and Narrative Review

Weiye Wang et al. J Alzheimers Dis Rep. .

Abstract

Cognitive impairment is a primary manifestation of neurological symptoms associated with COVID-19 and may occur after disease resolution. Although cognitive impairment has been extensively reported in the literature, its duration and rate of remission remain controversial. This study discusses the various factors that influence cognitive impairment, including demographic characteristics, genetics, as well as disease course and severity. Furthermore, imaging and laboratory data have suggested various associations with cognitive impairment, most notably changes in EEG patterns, PET imaging, and serum markers. Some findings suggest similarities and potential links between COVID-related cognitive impairment and Alzheimer's disease. Moreover, this study reviews the various mechanisms proposed to explain the development of cognitive impairment in COVID-19, including cytokine storm, damage to the blood-brain barrier, compromise of small vessel integrity, hypoxic conditions, and immune dysregulation.

Keywords: Alzheimer’s disease; COVID-19; SARS-CoV-2; cognitive impairment; mechanism; nervous system.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Possible pathophysiological mechanisms of cognitive impairment in COVID-19.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Dewanjee S, Vallamkondu J, Kalra RS, Puvvada N, Kandimalla R, Reddy PH (2021) Emerging COVID-19 neurological manifestations: Present outlook and potential neurological challenges in COVID-19 pandemic. Mol Neurobiol 58, 4694–4715. - PMC - PubMed
    1. Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, Ekka-Zohar A, Ben David SS, Lerner U, Bivas-Benita M, Greenfeld S (2023) Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ 380, e072529. - PMC - PubMed
    1. Proal AD, VanElzakker MB (2021) Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front Microbiol 12, 698169. - PMC - PubMed
    1. Mehandru S, Merad M (2022) Pathological sequelae of long-haul COVID. Nat Immunol 23, 194–202. - PMC - PubMed
    1. Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: Major findings, mechanisms and recommendations. Nat Rev Microbiol 21, 133–146. - PMC - PubMed

LinkOut - more resources